Free Trial
→ Urgent Attention to Executive Order #14363 (Buy This Stock Before Oct. 20th (From Chaikin Analytics) (Ad)tc pixel Free WOK Stock Alerts

WORK Medical Technology Group (WOK) Competitors

WORK Medical Technology Group logo
$1.44 -0.09 (-5.88%)
Closing price 03:59 PM Eastern
Extended Trading
$1.46 +0.02 (+1.39%)
As of 04:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

WOK vs. LUCYW, NXGLW, MDLN, ALC, and WST

Should you buy WORK Medical Technology Group stock or one of its competitors? WORK Medical Technology Group's main competitors and comparable companies include Innovative Eyewear (LUCYW), NEXGEL (NXGLW), Medline (MDLN), Alcon (ALC), and West Pharmaceutical Services (WST). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does WORK Medical Technology Group compare to Innovative Eyewear?

Innovative Eyewear (NASDAQ:LUCYW) and WORK Medical Technology Group (NASDAQ:WOK) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends, media sentiment and earnings.

In the previous week, Innovative Eyewear and Innovative Eyewear both had 2 articles in the media. WORK Medical Technology Group's average media sentiment score of 1.28 beat Innovative Eyewear's score of 0.55 indicating that WORK Medical Technology Group is being referred to more favorably in the news media.

Company Overall Sentiment
Innovative Eyewear Positive
WORK Medical Technology Group Positive

Company Net Margins Return on Equity Return on Assets
Innovative EyewearN/A N/A N/A
WORK Medical Technology Group N/A N/A N/A

Innovative Eyewear has higher earnings, but lower revenue than WORK Medical Technology Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Innovative Eyewear$3.41MN/AN/AN/AN/A
WORK Medical Technology Group$9.81MN/A-$1.07MN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Innovative Eyewear
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
WORK Medical Technology Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

WORK Medical Technology Group beats Innovative Eyewear on 3 of the 3 factors compared between the two stocks.

How does WORK Medical Technology Group compare to NEXGEL?

NEXGEL (NASDAQ:NXGLW) and WORK Medical Technology Group (NASDAQ:WOK) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and media sentiment.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NEXGEL
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
WORK Medical Technology Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

NEXGEL has higher revenue and earnings than WORK Medical Technology Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NEXGEL$12.07MN/AN/AN/AN/A
WORK Medical Technology Group$9.81MN/A-$1.07MN/AN/A

Company Net Margins Return on Equity Return on Assets
NEXGELN/A N/A N/A
WORK Medical Technology Group N/A N/A N/A

In the previous week, WORK Medical Technology Group had 1 more articles in the media than NEXGEL. MarketBeat recorded 2 mentions for WORK Medical Technology Group and 1 mentions for NEXGEL. NEXGEL's average media sentiment score of 1.82 beat WORK Medical Technology Group's score of 1.28 indicating that NEXGEL is being referred to more favorably in the media.

Company Overall Sentiment
NEXGEL Very Positive
WORK Medical Technology Group Positive

Summary

NEXGEL and WORK Medical Technology Group tied by winning 2 of the 4 factors compared between the two stocks.

How does WORK Medical Technology Group compare to Medline?

WORK Medical Technology Group (NASDAQ:WOK) and Medline (NASDAQ:MDLN) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, earnings, risk, valuation, profitability, institutional ownership, dividends and analyst recommendations.

Medline has higher revenue and earnings than WORK Medical Technology Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
WORK Medical Technology Group$9.81MN/A-$1.07MN/AN/A
Medline$28.43B1.68$1.16B$0.7945.90

Company Net Margins Return on Equity Return on Assets
WORK Medical Technology GroupN/A N/A N/A
Medline N/A N/A N/A

In the previous week, Medline had 19 more articles in the media than WORK Medical Technology Group. MarketBeat recorded 21 mentions for Medline and 2 mentions for WORK Medical Technology Group. WORK Medical Technology Group's average media sentiment score of 1.28 beat Medline's score of 0.34 indicating that WORK Medical Technology Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
WORK Medical Technology Group
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Medline
7 Very Positive mention(s)
0 Positive mention(s)
10 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Medline has a consensus target price of $46.81, suggesting a potential upside of 29.09%. Given Medline's stronger consensus rating and higher possible upside, analysts plainly believe Medline is more favorable than WORK Medical Technology Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
WORK Medical Technology Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Medline
1 Sell rating(s)
5 Hold rating(s)
21 Buy rating(s)
2 Strong Buy rating(s)
2.83

Summary

Medline beats WORK Medical Technology Group on 7 of the 8 factors compared between the two stocks.

How does WORK Medical Technology Group compare to Alcon?

Alcon (NYSE:ALC) and WORK Medical Technology Group (NASDAQ:WOK) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk, media sentiment and dividends.

Alcon has higher revenue and earnings than WORK Medical Technology Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alcon$10.40B3.05$980M$1.3148.90
WORK Medical Technology Group$9.81MN/A-$1.07MN/AN/A

Alcon has a net margin of 5.92% compared to WORK Medical Technology Group's net margin of 0.00%. Alcon's return on equity of 7.29% beat WORK Medical Technology Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Alcon5.92% 7.29% 5.09%
WORK Medical Technology Group N/A N/A N/A

Alcon has a beta of 0.88, indicating that its share price is 12% less volatile than the broader market. Comparatively, WORK Medical Technology Group has a beta of 1.75, indicating that its share price is 75% more volatile than the broader market.

In the previous week, Alcon had 3 more articles in the media than WORK Medical Technology Group. MarketBeat recorded 5 mentions for Alcon and 2 mentions for WORK Medical Technology Group. WORK Medical Technology Group's average media sentiment score of 1.28 beat Alcon's score of 0.32 indicating that WORK Medical Technology Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alcon
3 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
WORK Medical Technology Group
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Alcon presently has a consensus target price of $84.43, indicating a potential upside of 31.80%. Given Alcon's stronger consensus rating and higher possible upside, equities analysts clearly believe Alcon is more favorable than WORK Medical Technology Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alcon
1 Sell rating(s)
6 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
2.63
WORK Medical Technology Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

53.9% of Alcon shares are owned by institutional investors. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Alcon beats WORK Medical Technology Group on 11 of the 13 factors compared between the two stocks.

How does WORK Medical Technology Group compare to West Pharmaceutical Services?

WORK Medical Technology Group (NASDAQ:WOK) and West Pharmaceutical Services (NYSE:WST) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, valuation, media sentiment, risk, earnings and profitability.

West Pharmaceutical Services has a net margin of 16.98% compared to WORK Medical Technology Group's net margin of 0.00%. West Pharmaceutical Services' return on equity of 20.11% beat WORK Medical Technology Group's return on equity.

Company Net Margins Return on Equity Return on Assets
WORK Medical Technology GroupN/A N/A N/A
West Pharmaceutical Services 16.98%20.11%14.83%

In the previous week, West Pharmaceutical Services had 4 more articles in the media than WORK Medical Technology Group. MarketBeat recorded 6 mentions for West Pharmaceutical Services and 2 mentions for WORK Medical Technology Group. WORK Medical Technology Group's average media sentiment score of 1.28 beat West Pharmaceutical Services' score of 0.65 indicating that WORK Medical Technology Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
WORK Medical Technology Group
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
West Pharmaceutical Services
1 Very Positive mention(s)
3 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

West Pharmaceutical Services has higher revenue and earnings than WORK Medical Technology Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
WORK Medical Technology Group$9.81MN/A-$1.07MN/AN/A
West Pharmaceutical Services$3.07B8.38$493.70M$7.8146.87

West Pharmaceutical Services has a consensus price target of $385.33, indicating a potential upside of 5.26%. Given West Pharmaceutical Services' stronger consensus rating and higher possible upside, analysts plainly believe West Pharmaceutical Services is more favorable than WORK Medical Technology Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
WORK Medical Technology Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
West Pharmaceutical Services
0 Sell rating(s)
2 Hold rating(s)
12 Buy rating(s)
0 Strong Buy rating(s)
2.86

WORK Medical Technology Group has a beta of 1.75, indicating that its stock price is 75% more volatile than the broader market. Comparatively, West Pharmaceutical Services has a beta of 1.13, indicating that its stock price is 13% more volatile than the broader market.

93.9% of West Pharmaceutical Services shares are held by institutional investors. 0.6% of West Pharmaceutical Services shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

West Pharmaceutical Services beats WORK Medical Technology Group on 11 of the 13 factors compared between the two stocks.

Get WORK Medical Technology Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for WOK and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WOK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WOK vs. The Competition

Export
MetricWORK Medical Technology GroupHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$5.56B$7.26B$13.21B
Dividend YieldN/A1.77%2.53%22.58%
P/E RatioN/A25.89275.6725.84
Price / SalesN/A70.42579.8079.34
Price / CashN/A32.5627.3036.12
Price / BookN/A6.0210.856.10
Net Income-$1.07M$146.14M$3.50B$380.59M
7 Day Performance-1.71%-0.64%-2.06%-2.29%
1 Month Performance-23.40%-2.17%-4.80%-4.18%
1 Year Performance-100.00%4.36%6.18%0.57%

WORK Medical Technology Group Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WOK
WORK Medical Technology Group
N/A$1.44
-5.9%		N/A-100.0%$0.00$9.81MN/A238
LUCYW
Innovative Eyewear
N/A$0.03
-28.8%		N/A-68.0%$0.00$3.41MN/A13
NXGLW
NEXGEL
N/A$0.01
+4.0%		N/A-96.3%$0.00$12.07MN/A19
MDLN
Medline
3.0765 of 5 stars		$35.45
-0.3%		$46.88
+32.3%		N/A$46.74B$28.43BN/A45,000
ALC
Alcon
3.5902 of 5 stars		$62.96
-0.4%		$84.43
+34.1%		-11.0%$31.25B$10.40B48.0625,942

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:WOK) was last updated on 10/12/2026 by MarketBeat.com Staff.
From Our Partners
A new income category is drawing serious money - here's why
Forbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...
Investors Alley | Sponsoredtc pixel
Palantir and Wall Street are in on it…
Palantir just signed a major AI deal with a company most investors have never heard of. Wall Street has pou...
Monument Traders Alliance | Sponsoredtc pixel
Trump goes "all-in" on Grand Canyon energy breakthrough
A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...
Behind the Markets | Sponsoredtc pixel
Why major institutions are piling into this digital asset now
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely | Sponsoredtc pixel
My biggest prediction yet?!
James Altucher called Facebook's rise past 100 billion dollars in 2007 and Apple's run to a trillion years lat...
Paradigm Press | Sponsoredtc pixel
Fox News: Wall Street Can Seize Your Retirement
Fox News reported that under current law, legal title to most stocks and bonds sits with a central institution...
Monetary Gold | Sponsoredtc pixel
The AI Stock to Keep an Eye on Before Election Day (See Why)
In 2019, Charles Mizrahi named Marvell Technology his top AI pick. It's since climbed 1300 percent. Now he'...
Prosperity Research | Sponsoredtc pixel
Trump To Relaunch USD?
President Trump's summit with Xi Jinping drew headlines for tariffs and trade truces, but the real story may b...
Porter & Company | Sponsoredtc pixel